Analysis of HLA-E peptide-binding specificity and contact residues in bound peptide required for recognition by CD94/NKG2.
about
Structural basis for NKG2A/CD94 recognition of HLA-E.Newtonian cell interactions shape natural killer cell educationImmune modulation in xenotransplantationCD94-NKG2A recognition of human leukocyte antigen (HLA)-E bound to an HLA class I leader sequenceCharacteristics of HLA-E Restricted T-Cell Responses and Their Role in Infectious DiseasesThe nonpolymorphic MHC Qa-1b mediates CD8+ T cell surveillance of antigen-processing defectsStructural basis for a major histocompatibility complex class Ib-restricted T cell responseNKG2A inhibits TH2 cell effector function in vitro.Mycobacterium tuberculosis peptides presented by HLA-E molecules are targets for human CD8 T-cells with cytotoxic as well as regulatory activityExpression of the mouse MHC class Ib H2-T11 gene product, a paralog of H2-T23 (Qa-1) with shared peptide-binding specificity.Genetic modification of pigs as organ donors for xenotransplantation.Human CD8+ T-cells recognizing peptides from Mycobacterium tuberculosis (Mtb) presented by HLA-E have an unorthodox Th2-like, multifunctional, Mtb inhibitory phenotype and represent a novel human T-cell subset.NKG2A and CD56 are coexpressed on activated TH2 but not TH1 lymphocytesA Conserved HIV-1-Derived Peptide Presented by HLA-E Renders Infected T-cells Highly Susceptible to Attack by NKG2A/CD94-Bearing Natural Killer Cells.Regulation of self-tolerance by Qa-1-restricted CD8(+) regulatory T cellsHLA-B signal peptide polymorphism influences the rate of HIV-1 acquisition but not viral loadBroadly targeted CD8⁺ T cell responses restricted by major histocompatibility complex E.Polymorphism in human cytomegalovirus UL40 impacts on recognition of human leukocyte antigen-E (HLA-E) by natural killer cells.The major histocompatibility complex class Ib molecule HLA-E at the interface between innate and adaptive immunity.Natural Killer Cell Receptor NKG2A/HLA-E Interaction Dependent Differential Thymopoiesis of Hematopoietic Progenitor Cells Influences the Outcome of HIV Infection.Non-classical MHC-E (Mamu-E) expression in the rhesus monkey placenta.Targeting Non-classical Myelin Epitopes to Treat Experimental Autoimmune EncephalomyelitisHuman natural killer receptors, co-receptors, and their ligands.Isoforms of the nonclassical class I MHC antigen H2-Q5 are enriched in brain and encode Qdm peptide.A bird's eye view of NK cell receptor interactions with their MHC class I ligands.The HLA-A2 restricted T cell epitope HCV core 35-44 stabilizes HLA-E expression and inhibits cytolysis mediated by natural killer cellsNK cells generate memory-type responses to human cytomegalovirus-infected fibroblasts.HLA-E: Presentation of a Broader Peptide Repertoire Impacts the Cellular Immune Response-Implications on HSCT Outcome.Diversification of both KIR and NKG2 natural killer cell receptor genes in macaques - implications for highly complex MHC-dependent regulation of natural killer cells.Paired opposing leukocyte receptors recognizing rapidly evolving ligands are subject to homogenization of their ligand binding domains.A viral, transporter associated with antigen processing (TAP)-independent, high affinity ligand with alternative interactions endogenously presented by the nonclassical human leukocyte antigen E class I molecule.Introduction: MHC/KIR and governance of specificity.Critical role of Qa1b in the protection of mature dendritic cells from NK cell-mediated killing.Naive Donor NK Cell Repertoires Associated with Less Leukemia Relapse after Allogeneic Hematopoietic Stem Cell Transplantation.HLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cells.HLA-E expression on porcine cells: protection from human NK cytotoxicity depends on peptide loading.Cloning, sequencing, and polymorphism analysis of novel classical MHC class I alleles in northern pig-tailed macaques (Macaca leonina).Crystal structure of Qa-1a with bound Qa-1 determinant modifier peptide.Peptide-induced HLA-E expression in human PBMCs is dependent on peptide sequence and the HLA-E genotype.Dimorphic HLA-B signal peptides differentially influence HLA-E- and natural killer cell-mediated cytolysis of HIV-1-infected target cells.
P2860
Q24336854-D329B21D-B171-49F3-9386-3D4DEFCDCBC7Q26797240-88BF32F3-0FF1-4301-A39B-4408E51A8A85Q26826905-B4A476CA-9281-4815-8A30-1AC6284452A1Q27650047-19BB7057-1F11-4BB6-8729-F6D88B80EC7DQ28079186-5EA3039B-2FC1-4A4E-AE1F-01F42A266A33Q28512131-3E6FAEEC-1611-4B41-ABE9-5512CC41F4B9Q28941762-8711DD59-2443-4CCD-BC4E-60A0637D3687Q33302211-49D0CABF-C7CE-4B0E-A1FD-E03F7ABBBC06Q33535876-2FC9BEA5-9CC1-4C2E-8A4C-90B65DD98E12Q34414261-C8E728E9-A1CC-4DBA-9E86-2844D49A194EQ35016869-58DCA028-E7B2-429F-A461-3561A0DB22EBQ35214233-72AD4DA4-4B35-4268-981F-BA80F5D66AACQ35750302-54EF8D59-59BA-4DDF-9D5F-6A6FEDF5A0C0Q35909272-D883A6C0-918E-428E-A747-9FF748D200FFQ36244210-246C2D71-A1F2-4E64-BAEA-B7AC53C47993Q36606569-E9A25505-8C9F-4C8E-A8F7-798944F72499Q36624194-DAC2A40C-9D61-4C5F-94A0-2D4C3D1BD26DQ36708679-923AAAC9-DAC2-4BCA-8DB5-A4A5260C3D71Q37306670-4D9B96FF-AC3D-433A-9429-601A2B80DB53Q37324272-CD1C7891-9443-4021-8F44-89A9AA1D4A64Q37369690-838B1065-07E4-4D7F-AECE-E2AE15517774Q37379542-57926909-31F4-46FE-9268-22CC187D2E72Q37399014-A30A5A33-FADF-44F2-9AAC-9FE42B411736Q38339912-F515F1F5-4CB6-441E-AC24-F868EEB0C676Q38568874-61D74393-08A3-4E29-AF59-771CA2904846Q38585283-6C676FF1-6FF8-42AC-AAD4-8E99252FF631Q38802393-E7ED721C-CEFE-477F-BF37-2F5186C7805CQ38835585-5F6BF1FC-95AB-4893-9B61-4AA559265BBDQ38938255-6FCBD5A5-D123-40FC-A065-CC590F2ACF51Q38986444-33C00FAD-C19E-48D5-914A-EC182B9480C9Q39289753-4FCEFBBD-95B5-4689-BC7A-D802A271FF64Q39427560-3AF68E0A-2774-4307-B160-B959721731F0Q40047518-0FC2F304-6D94-4E82-8FAE-846A7A687C95Q40128190-58CF115E-0B5B-44A3-AA20-B64BA9210282Q40201364-1C9D989A-4365-4BF4-AC1D-AECF59EF2411Q40386340-00D0E02D-AA4D-4C70-968B-971D189F99BEQ40827783-1D751750-CAA8-4C34-BACC-4895274723E9Q41216588-C4B14F3C-E6FD-4118-8EE1-4CCF756C661DQ41307787-835ED13E-F33B-4D08-96AB-8A13F8318A34Q42276242-F02C49C3-2BD7-43C4-BF58-4255A8A62859
P2860
Analysis of HLA-E peptide-binding specificity and contact residues in bound peptide required for recognition by CD94/NKG2.
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Analysis of HLA-E peptide-bind ...... for recognition by CD94/NKG2.
@ast
Analysis of HLA-E peptide-bind ...... for recognition by CD94/NKG2.
@en
type
label
Analysis of HLA-E peptide-bind ...... for recognition by CD94/NKG2.
@ast
Analysis of HLA-E peptide-bind ...... for recognition by CD94/NKG2.
@en
prefLabel
Analysis of HLA-E peptide-bind ...... for recognition by CD94/NKG2.
@ast
Analysis of HLA-E peptide-bind ...... for recognition by CD94/NKG2.
@en
P2093
P1476
Analysis of HLA-E peptide-bind ...... for recognition by CD94/NKG2.
@en
P2093
Chris Ibegbu
Dominique A Weber
John D Altman
Joseph D Miller
Peter E Jensen
P304
P356
10.4049/JIMMUNOL.171.3.1369
P407
P577
2003-08-01T00:00:00Z